Literature DB >> 23248974

[Adenosine deaminase in severe combined immunodeficiency syndrome].

Mary Carmen Pérez-Aguilar1, Loredana Goncalves, Rafael Bonfante-Cabarcas.   

Abstract

Adenosine deaminase is an enzyme of the purine metabolism whose function is to convert adenosine to inosine and deoxyadenosine to deoxyinosine. The ecto-ADA1 binding to the cell surface through CD26 contributes to the regulation of cytokines and stimulates the proliferation of T cells by activating CD45. The deficiency of this enzyme generates the severe combined immunodeficiency syndrome, characterized by the accumulation of deoxyadenosine and adenine metabolites, which have toxic effects on lymphocytes, affecting DNA synthesis and consequently, clonal expansion. Early diagnosis of this immunodeficiency is essential, as it significantly reduces morbidity and mortality associated with recurrent infections. Recent advances in molecular biology and genetics have led to the identification of genetic defects of many primary immunodeficiencies and the development of promising diagnostic tools and treatment.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23248974

Source DB:  PubMed          Journal:  Invest Clin        ISSN: 0535-5133            Impact factor:   0.683


  2 in total

Review 1.  Periodontal and other oral manifestations of immunodeficiency diseases.

Authors:  M E Peacock; R M Arce; C W Cutler
Journal:  Oral Dis       Date:  2016-10-10       Impact factor: 3.511

2.  Adenosine Depletion as A New Strategy to Decrease Glioblastoma Stem-Like Cells Aggressiveness.

Authors:  Ignacio Niechi; Atenea Uribe-Ojeda; José Ignacio Erices; Ángelo Torres; Daniel Uribe; José Dellis Rocha; Pamela Silva; Hans G Richter; Rody San Martín; Claudia Quezada
Journal:  Cells       Date:  2019-10-30       Impact factor: 6.600

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.